The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China

Abstract Background This study investigated the relationship between fibroblast growth factor 21 (FGF-21) and newly diagnosed type-2 diabetes mellitus (T2DM). Methods In this cross-sectional study, FGF-21 and T2DM risk were analyzed using restricted cubic splines with univariate or multivariate logi...

Full description

Bibliographic Details
Main Authors: Lili You, Xiaosi Hong, Hongshi Wu, Diefei Liang, Feng Li, Dinghao Zheng, Xiuwei Zhang, Dan Liu, Qingyu Chen, Li Yan, Meng Ren, Wei Wang
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12902-023-01426-y
_version_ 1797559131931934720
author Lili You
Xiaosi Hong
Hongshi Wu
Diefei Liang
Feng Li
Dinghao Zheng
Xiuwei Zhang
Dan Liu
Qingyu Chen
Li Yan
Meng Ren
Wei Wang
author_facet Lili You
Xiaosi Hong
Hongshi Wu
Diefei Liang
Feng Li
Dinghao Zheng
Xiuwei Zhang
Dan Liu
Qingyu Chen
Li Yan
Meng Ren
Wei Wang
author_sort Lili You
collection DOAJ
description Abstract Background This study investigated the relationship between fibroblast growth factor 21 (FGF-21) and newly diagnosed type-2 diabetes mellitus (T2DM). Methods In this cross-sectional study, FGF-21 and T2DM risk were analyzed using restricted cubic splines with univariate or multivariate logistic regression analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated via logistic regression analysis. Cluster and subgroup analyses were conducted to evaluate the associations between FGF-21 and diabetes in different subpopulations. Nomograms and ROC curves were used to explore the clinical utility of FGF-21 in the diabetes assessment model. Results High levels of FGF-21 were significantly associated with a high risk of T2DM after adjusting for confounding factors in both the total population and subpopulations (P for trend < 0.001). In the total population, the ORs of diabetes with increasing FGF-21 quartiles were 1.00 (reference), 1.24 (95% CI 0.56–2.80; quartile 2), 2.47 (95% CI 1.18–5.33; quartile 3), and 3.24 (95% CI 1.53–7.14; quartile 4) in Model 4 (P < 0.001), and the trend was consistent in different subpopulations. In addition, compared with the model constructed with conventional noninvasive indicators, the AUC of the model constructed by adding FGF-21 was increased from 0.668 (95% CI: 0.602–0.733) to 0.715 (95% CI: 0.654–0.777), indicating that FGF-21 could significantly improve the risk-assessment efficiency of type-2 diabetes. Conclusion This study demonstrated that a high level of circulating FGF-21 was positively correlated with diabetes, and levels of FGF-21 could be an important biomarker for the assessment of diabetes risk.
first_indexed 2024-03-10T17:41:05Z
format Article
id doaj.art-b91981043bd347dcbc7cdc76b1f95af1
institution Directory Open Access Journal
issn 1472-6823
language English
last_indexed 2024-03-10T17:41:05Z
publishDate 2023-09-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj.art-b91981043bd347dcbc7cdc76b1f95af12023-11-20T09:42:01ZengBMCBMC Endocrine Disorders1472-68232023-09-0123111110.1186/s12902-023-01426-yThe association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern ChinaLili You0Xiaosi Hong1Hongshi Wu2Diefei Liang3Feng Li4Dinghao Zheng5Xiuwei Zhang6Dan Liu7Qingyu Chen8Li Yan9Meng Ren10Wei Wang11Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Dongguan People’s HospitalDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Medical Examination Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityAbstract Background This study investigated the relationship between fibroblast growth factor 21 (FGF-21) and newly diagnosed type-2 diabetes mellitus (T2DM). Methods In this cross-sectional study, FGF-21 and T2DM risk were analyzed using restricted cubic splines with univariate or multivariate logistic regression analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated via logistic regression analysis. Cluster and subgroup analyses were conducted to evaluate the associations between FGF-21 and diabetes in different subpopulations. Nomograms and ROC curves were used to explore the clinical utility of FGF-21 in the diabetes assessment model. Results High levels of FGF-21 were significantly associated with a high risk of T2DM after adjusting for confounding factors in both the total population and subpopulations (P for trend < 0.001). In the total population, the ORs of diabetes with increasing FGF-21 quartiles were 1.00 (reference), 1.24 (95% CI 0.56–2.80; quartile 2), 2.47 (95% CI 1.18–5.33; quartile 3), and 3.24 (95% CI 1.53–7.14; quartile 4) in Model 4 (P < 0.001), and the trend was consistent in different subpopulations. In addition, compared with the model constructed with conventional noninvasive indicators, the AUC of the model constructed by adding FGF-21 was increased from 0.668 (95% CI: 0.602–0.733) to 0.715 (95% CI: 0.654–0.777), indicating that FGF-21 could significantly improve the risk-assessment efficiency of type-2 diabetes. Conclusion This study demonstrated that a high level of circulating FGF-21 was positively correlated with diabetes, and levels of FGF-21 could be an important biomarker for the assessment of diabetes risk.https://doi.org/10.1186/s12902-023-01426-yType 2 diabetes mellitusFibroblast growth factor 21BiomarkerRisk assessment model
spellingShingle Lili You
Xiaosi Hong
Hongshi Wu
Diefei Liang
Feng Li
Dinghao Zheng
Xiuwei Zhang
Dan Liu
Qingyu Chen
Li Yan
Meng Ren
Wei Wang
The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
BMC Endocrine Disorders
Type 2 diabetes mellitus
Fibroblast growth factor 21
Biomarker
Risk assessment model
title The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
title_full The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
title_fullStr The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
title_full_unstemmed The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
title_short The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
title_sort association of fgf 21 with the risk of newly diagnosed type 2 diabetes mellitus a cross sectional study in southern china
topic Type 2 diabetes mellitus
Fibroblast growth factor 21
Biomarker
Risk assessment model
url https://doi.org/10.1186/s12902-023-01426-y
work_keys_str_mv AT liliyou theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT xiaosihong theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT hongshiwu theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT diefeiliang theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT fengli theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT dinghaozheng theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT xiuweizhang theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT danliu theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT qingyuchen theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT liyan theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT mengren theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT weiwang theassociationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT liliyou associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT xiaosihong associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT hongshiwu associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT diefeiliang associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT fengli associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT dinghaozheng associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT xiuweizhang associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT danliu associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT qingyuchen associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT liyan associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT mengren associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina
AT weiwang associationoffgf21withtheriskofnewlydiagnosedtype2diabetesmellitusacrosssectionalstudyinsouthernchina